<DOC>
	<DOC>NCT01929421</DOC>
	<brief_summary>To assess the efficacy and safety of salvage tratment with Gemcitabine and S-1 Combination in metastatic colorectal cancer</brief_summary>
	<brief_title>A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>non resectable colorectal adenocarcinoma. disease progression during or within 6months after treatment with irinotecan and oxaliplatin contaning regimens. estimated life expectancy of more than 3 months. ECOG status 2 or lower other tumor type than adenoarcinoma. presence or history of CNS metastasis. evidence of gastrointestinal bleeding.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>S-1</keyword>
</DOC>